Randomized Phase I/II Study to Evaluate the Safety and Immunogenicity of MG 1109 (Egg-based, Pre-pandemic Influenza(H5N1) Vaccine); Administered Intramuscularly in Healthy Adult Volunteers

Trial Profile

Randomized Phase I/II Study to Evaluate the Safety and Immunogenicity of MG 1109 (Egg-based, Pre-pandemic Influenza(H5N1) Vaccine); Administered Intramuscularly in Healthy Adult Volunteers

Completed
Phase of Trial: Phase I/II

Latest Information Update: 25 Aug 2016

At a glance

  • Drugs Influenza A virus vaccine-H5N1 (Primary)
  • Indications Influenza A virus infections
  • Focus Adverse reactions; Pharmacodynamics; Registrational
  • Most Recent Events

    • 25 Aug 2011 New source identified and integrated (Korean Clinical Trials Register KCT0000119)
    • 12 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top